Lenvatinib May Up Survival in Anaplastic Thyroid Cancer Lenvatinib May Up Survival in Anaplastic Thyroid Cancer

Among patients with unresectable anaplastic thyroid cancer treated with lenvatinib, average survival was prolonged. The study was published as a preprint and has not yet been peer reviewed.First Look
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news